Essex Investment Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
CIP
FLAM
FAM
Essex Investment Management's ATRC Position: Q4 2023 in Review
Essex Investment Management sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 52,907 shares — an estimated $2.32M sold.
Essex Investment Management first reported a position in ATRC in Q2 2013 and held it in 23 quarters. The position peaked at $3.46M in Q2 2017. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.
- Essex Investment Management reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
- Essex Investment Management sold 52,907 AtriCure shares in Q4 2023, an estimated $2.32M.
- Essex Investment Management first reported a position in AtriCure in Q2 2013 and held it in 23 quarters.
- Essex Investment Management's AtriCure position peaked at $3.46M in Q2 2017.
- 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.
Based on Essex Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.